These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 15765594

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
    Derouin F.
    Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Preliminary application of PCR to curative effect assessment of chemotherapy against experimental acute infection of Toxoplasma gondii in mice].
    Xiang X, Ke OY, Zhang Z.
    Hunan Yi Ke Da Xue Xue Bao; 1997 Jun; 22(1):5-7. PubMed ID: 9868016
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
    Martins-Duarte ÉS, de Souza W, Vommaro RC.
    Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
    Romand S, Pudney M, Derouin F.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
    [Abstract] [Full Text] [Related]

  • 13. Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo.
    Si H, Xu C, Zhang J, Zhang X, Li B, Zhou X, Zhang J.
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):238-245. PubMed ID: 29684680
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis.
    Montazeri M, Emami S, Asgarian-Omran H, Azizi S, Sharif M, Sarvi S, Rezaei F, Sadeghi M, Gohardehi S, Daryani A.
    Exp Parasitol; 2019 May; 200():7-12. PubMed ID: 30904693
    [Abstract] [Full Text] [Related]

  • 15. Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.
    Derouin F, Almadany R, Chau F, Rouveix B, Pocidalo JJ.
    Antimicrob Agents Chemother; 1992 May; 36(5):997-1001. PubMed ID: 1324642
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
    Alder J, Hutch T, Meulbroek JA, Clement JC.
    J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1141-8. PubMed ID: 7932081
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of the efficacy of prolonged administration of azithromycin in a murine model of chronic toxoplasmosis.
    Dumas JL, Chang R, Mermillod B, Piguet PF, Comte R, Pechère JC.
    J Antimicrob Chemother; 1994 Jul; 34(1):111-8. PubMed ID: 7961197
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.